0.5667
Senseonics Holdings Inc stock is traded at $0.5667, with a volume of 4.66M.
It is down -7.66% in the last 24 hours and down -56.74% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$0.6137
Open:
$0.6232
24h Volume:
4.66M
Relative Volume:
0.34
Market Cap:
$369.40M
Revenue:
$22.39M
Net Income/Loss:
$-60.39M
P/E Ratio:
-5.0689
EPS:
-0.1118
Net Cash Flow:
$-70.51M
1W Performance:
-7.73%
1M Performance:
-56.74%
6M Performance:
+39.27%
1Y Performance:
+0.28%
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Compare SENS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SENS
Senseonics Holdings Inc
|
0.5667 | 369.40M | 22.39M | -60.39M | -70.51M | -0.1118 |
![]()
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-19-23 | Initiated | Jefferies | Underperform |
Aug-19-21 | Initiated | H.C. Wainwright | Buy |
Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
Oct-23-19 | Initiated | Stifel | Buy |
Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
Jan-29-19 | Initiated | Piper Jaffray | Neutral |
Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
SENS (Senseonics Holdings) Owner Earnings per Share (TTM) : -0.12 (As of Dec. 2024) - GuruFocus.com
HC Wainwright Reiterates Buy Rating for Senseonics (NYSE:SENS) - Defense World
Senseonics Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Senseonics (SENS) Upgraded to Buy: What Does It Mean for the Stock? - MSN
H.C. Wainwright maintains Buy rating on Senseonics stock at $2 target - Investing.com Canada
Senseonics Target of Unusually High Options Trading (NYSE:SENS) - Defense World
Stifel maintains Buy on Senseonics, reiterates $2.50 target By Investing.com - Investing.com South Africa
Senseonics Earnings Call: Eversense 365 Shines Amid Challenges - TipRanks
Raymond James maintains Underperform on Senseonics stock By Investing.com - Investing.com South Africa
Stifel maintains Buy on Senseonics, reiterates $2.50 target - Investing.com
Senseonics Holdings, Inc. (AMEX:SENS) Q4 2024 Earnings Call Transcript - Insider Monkey
Senseonics Holdings revenue hits USD 8.3M in Q4 2024 - Medical Buyer
Senseonics Expects 2025 Revenue To Rise By 51% To 69% - Nasdaq
Senseonics Reports Growth and Eversense 365 Launch - MSN
Senseonics Holdings Inc (SENS) Q4 2024 Earnings Call Highlights: Eversense 365 Launch and ... - Yahoo Finance
Senseonics Holdings (SENS) Reports Q4 Loss - MSN
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Senseonics Holdings Inc earnings beat, revenue topped estimates - Investing.com Australia
Senseonics Holdings Inc earnings beat, revenue topped estimates By Investing.com - Investing.com Canada
Senseonics stock rises 4.6% on earnings beat, revenue growth By Investing.com - Investing.com South Africa
Senseonics beats on Q4 earnings; bullish 2025 revenue outlook - MSN
Senseonics' Q4 Net Loss Narrows, Revenue Rises; 2025 Revenue Outlook Set - Marketscreener.com
Senseonics stock rises 4.6% on earnings beat, revenue growth - Investing.com India
Senseonics: Q4 Earnings Snapshot - San Antonio Express-News
Can Senseonics' 56% Patient Growth Offset $78.6M Loss? Q4 Earnings Deep Dive - StockTitan
What To Expect From Senseonics Holdings Inc (SENS) Q4 2024 Earnings - Yahoo Finance
Earnings call transcript: Senseonics Q4 2024 sees revenue dip, strategic shifts - Investing.com
Investor Network: Senseonics Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care - GlobeNewswire
SENS stock soars to 52-week high, touches $0.93 amid robust gains - MSN
Senseonics (NYSE:SENS) Shares Gap UpHere's Why - MarketBeat
Senseonics (NYSE:SENS) Sets New 1-Year HighWhat's Next? - MarketBeat
Senseonics (NYSE:SENS) Stock Price Down 5.7%Time to Sell? - MarketBeat
Senseonics (NYSE:SENS) Hits New 52-Week HighHere's Why - MarketBeat
Senseonics stock soars to 52-week high of $1.21 amid robust gains - MSN
Senseonics To Announce Q4 Results Next MonthWhy Keeping Watch Over SENS Makes Sense - RTTNews
Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Senseonics to Present Implantable CGM Technology at TD Cowen Healthcare Conference | SENS Stock News - StockTitan
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time - The Manila Times
Senseonics Holdings, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025 - Nasdaq
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full - GlobeNewswire
Q4 Earnings Preview: Can Senseonics' Revolutionary Diabetes Tech Drive Growth in 2025? - StockTitan
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):